Risk adjusted net present value: What is the current valuation of Novo Nordisk’s Denecimig?

Denecimig is a monoclonal antibody commercialized by Novo Nordisk, with a leading Phase III program in Hemophilia A (Factor VIII Deficiency).

Doc’s Murderer Imprisoned; Butt Injection Arrest; Free Botox for Sex

A man was sentenced to 99 years in prison for the 2017 murder of Alaska surgeon Eric Garcia, MD. (Alaska’s News Source) A mother and

April 12, 2024

Impella CP pump shows survival benefit in cardiogenic shock

Implantation of the Impella CP micro-axial flow pump in the hours after a heart attack significantly increased the rate of survival at six months among

April 8, 2024

AI boosts breast cancer detection rates while cutting radiologist workload

AI-supported mammography screening significantly increases breast cancer detection rates while maintaining comparable recall rates, offering a safer and more efficient solution to address radiologist workloads.

January 9, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.